Literature DB >> 27732765

Graft-Versus-Host Disease Following Liver Transplantation: Development of a High-Incidence Rat Model and a Selective Prevention Method.

E Yu1,2, H Ueta1, H Kimura1, Y Kitazawa1, Y Sawanobori1, K Matsuno1.   

Abstract

Graft-versus-host disease (GvHD) following liver transplantation (LT) is a rare but serious complication with no presently available animal model and no preventive measures. To develop a rat model of GvHD after LT (LT-GvHD), we preconditioned hosts with sublethal irradiation plus reduction of natural killer (NK) cells with anti-CD8α mAb treatment, which invariably resulted in acute LT-GvHD. Compared with those in the peripheral counterpart, graft CD4+ CD25- passenger T cells showed lower alloreactivities in mixed leukocyte culture. Immunohistology revealed that donor CD4+ T cells migrated and formed clusters with host dendritic cells in secondary lymphoid organs, with early expansion and subsequent accumulation in target organs. For selectively preventing GvHD, donor livers were perfused ex vivo with organ preservation media containing anti-TCRαβ mAb. T cell-depleted livers almost completely suppressed clinical GvHD such that host rats survived for >100 days. Our results showed that passenger T cells could develop typical LT-GvHD if resistant cells such as host radiosensitive cells and host radioresistant NK cells were suppressed. Selective ex vivo T cell depletion prevented LT-GvHD without affecting host immunity or graft function. This method might be applicable to clinical LT in prediagnosed high-risk donor-recipient combinations and for analyzing immunoregulatory mechanisms of the liver.
© 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research/science; graft-versus-host disease (GVHD); immunohistochemistry; immunosuppression/immune modulation; immunosuppressive regimens; liver transplantation/hepatology; natural killer (NK) cells/NK receptors; organ perfusion and preservation; pathology/histopathology; translational research/science

Mesh:

Year:  2016        PMID: 27732765     DOI: 10.1111/ajt.14077

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal Endothelium Prevents Complement-Dependent Tissue Damage.

Authors:  Paolo Durigutto; Daniele Sblattero; Stefania Biffi; Luca De Maso; Chiara Garrovo; Gabriele Baj; Federico Colombo; Fabio Fischetti; Antonio F Di Naro; Francesco Tedesco; Paolo Macor
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

2.  Single blood transfusion induces the production of donor-specific alloantibodies and regulatory T cells mainly in the spleen.

Authors:  Hisashi Ueta; Yusuke Kitazawa; Yasushi Sawanobori; Takamasa Ueno; Satoshi Ueha; Kouji Matsushima; Kenjiro Matsuno
Journal:  Int Immunol       Date:  2018-03-08       Impact factor: 4.823

3.  Rapid immunosurveillance by recirculating lymphocytes in the rat intestine: critical role of unsulfated sialyl-Lewis X on high endothelial venules of the Peyer's patches.

Authors:  Tomomi Uchida; Hisashi Ueta; Xue-Dong Xu; Jotaro Hirakawa; Kazunori Tahara; Shu Zhou; Yasushi Sawanobori; Szandor Simmons; Yusuke Kitazawa; Hiroto Kawashima; Kenjiro Matsuno
Journal:  Int Immunol       Date:  2018-02-03       Impact factor: 4.823

4.  Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes.

Authors:  Yusuke Kitazawa; Hisashi Ueta; Yasushi Sawanobori; Tomoya Katakai; Hiroyuki Yoneyama; Satoshi Ueha; Kouji Matsushima; Nobuko Tokuda; Kenjiro Matsuno
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

5.  Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells.

Authors:  Hisashi Ueta; Xue-Dong Xu; Bin Yu; Yusuke Kitazawa; Enqiao Yu; Yoshiaki Hara; Miwa Morita-Nakagawa; Shu Zhou; Yasushi Sawanobori; Satoshi Ueha; Kazuhito Rokutan; Toshiya Tanaka; Nobuko Tokuda; Kouji Matsushima; Kenjiro Matsuno
Journal:  Int Immunol       Date:  2021-04-22       Impact factor: 4.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.